|
| 37864829 | Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD. | J Crohns Colitis | 2024 |
| 37976264 | Clinical Predictors of Early and Late Endoscopic Recurrence Following Ileocolonic Resection in Crohn's Disease. | J Crohns Colitis | 2024 |
| 36662167 | Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. | Inflamm Bowel Dis | 2023 |
| 36266592 | Existing Bowel Preparation Quality Scales Are Reliable in the Setting of Centralized Endoscopy Reading. | Dig Dis Sci | 2023 |
| 37600767 | The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population. | Front Immunol | 2023 |
| 37080976 | Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients. | Nat Commun | 2023 |
| 37080587 | Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. | Gut | 2023 |
| 37326480 | Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases. | J Immunol | 2023 |
| 37263307 | Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives. | Gastroenterology | 2023 |
| 37354560 | Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium. | Inflamm Bowel Dis | 2023 |
| 36988594 | Vedolizumab for the Treatment of Chronic Pouchitis. | N Engl J Med | 2023 |
| 36788016 | Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesis. | Gut | 2023 |
| 34995534 | Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management? | Gastroenterology | 2022 |
| 36038634 | Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility. | Nat Genet | 2022 |
| 35643175 | Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation. | Gastroenterology | 2022 |
| 35798022 | Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. | Lancet Gastroenterol Hepatol | 2022 |
| 35788348 | CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. | Gastroenterology | 2022 |
| 36399768 | Measurement of Disease Activity of Pouchitis. | Diseases of the Colon and Rectum | 2022 |
| 34272937 | The Toronto IBD Global Endoscopic Reporting [TIGER] Score: A Single, Easy to Use Endoscopic Score for Both Crohn's Disease and Ulcerative Colitis Patients. | | 2022 |
| 33421628 | Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor. | Clinical Gastroenterology and Hepatology | 2022 |
| 35224787 | Treatment of severe hidradenitis Suppurativa and Fistulizing Crohn's disease with Guselkumab. | Journal of the European Academy of Dermatology and Venereology | 2022 |
| 35189386 | IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus. | Clin Gastroenterol Hepatol | 2022 |
| 34774224 | Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. | Lancet Gastroenterol Hepatol | 2022 |
| 34698823 | A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease Recurrence. | J Crohns Colitis | 2022 |
| 34999763 | Combined Histo-endoscopic Remission but not Endoscopic Healing Alone in Ulcerative Colitis is Associated with a Mucosal Transcriptional Profile Resembling Healthy Mucosa. | | 2022 |
| 35220795 | Clinical Features and Treatment Outcomes in Hidradenitis Suppurativa With Fistulizing Crohn's Disease: A Systematic Review. | Journal of Cutaneous Medicine and Surgery | 2022 |
| 34416186 | Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. | Lancet Gastroenterol Hepatol | 2021 |
| 36776648 | Serum Ustekinumab Concentrations Are Associated With Remission in Crohn's Disease Defined by a Serum-Based Endoscopic Healing Index. | Crohns Colitis 360 | 2021 |
| 34020510 | Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysis. | J Gastroenterol Hepatol | 2021 |
| 34293299 | Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk. | Gastroenterology | 2021 |
| 34077506 | Integrative Analysis of Colonic Biopsies from Inflammatory Bowel Disease Patients Identifies an Interaction Between Microbial Bile Acid-inducible Gene Abundance and Human Angiopoietin-like 4 Gene Expression. | | 2021 |
| 33581758 | The ileoanal pouch: the next frontier in inflammatory bowel disease. | Lancet Gastroenterology and Hepatology, The | 2021 |
| 33735522 | An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials. | Aliment Pharmacol Ther | 2021 |
| 33786600 | Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study. | | 2021 |
| 33731595 | Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's disease. | European Journal of Gastroenterology and Hepatology | 2021 |
| 33872568 | Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group. | Lancet Gastroenterol Hepatol | 2021 |
| 33600772 | Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease. | Am J Hum Genet | 2021 |
| 33359885 | Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort. | Gastroenterology | 2021 |
| 33269403 | Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment. | Inflamm Bowel Dis | 2021 |
| 33421512 | Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target. | Gastroenterology | 2021 |
| 34521888 | Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis. | Sci Rep | 2021 |
| 34402466 | Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patients. | Eur J Gastroenterol Hepatol | 2021 |
| 34613952 | Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease. | Clinical and Translational Gastroenterology | 2021 |
| 31043543 | Advancing Early Identification of Axial Spondyloarthritis: An Interobserver Comparison of Extended Role Practitioners and Rheumatologists. | Journal of Rheumatology | 2020 |
| 32068150 | Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases. | Clin Gastroenterol Hepatol | 2020 |
| 31954438 | Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group. | Lancet Gastroenterol Hepatol | 2020 |
| 31883337 | Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis. | Inflammatory Bowel Diseases | 2020 |
| 31711925 | Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins. | Gastroenterology | 2020 |
| 32328546 | Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness. | J Can Assoc Gastroenterol | 2020 |
| 33085973 | COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal. | | 2020 |